vs
STANDARD BIOTOOLS INC.（LAB）与RBB Bancorp（RBB）财务数据对比。点击上方公司名可切换其他公司
RBB Bancorp的季度营收约是STANDARD BIOTOOLS INC.的1.7倍（$32.3M vs $19.6M），RBB Bancorp净利率更高（31.5% vs -177.4%，领先208.9%），RBB Bancorp同比增速更快（12.6% vs -11.5%），RBB Bancorp自由现金流更多（$42.6M vs $-23.1M），过去两年RBB Bancorp的营收复合增速更高（7.0% vs -12.2%）
Standard BioTools（原Fluidigm公司）是一家美国生命科学工具企业，主营流式细胞术与组织成像分析用质谱流式系统，以及配套的检测试剂盒与试剂，同时供应自动化基因组分析仪器、各类微流控芯片（又称集成流体电路）及配套试剂耗材，全系列产品及应用场景均可提供定制检测方案与相关服务。
RBB银行控股公司是总部位于美国的金融控股集团，旗下核心主体为皇家商业银行，主要服务亚裔社群、中小微企业、不动产投资者及零售客户，提供商业信贷、储蓄存款、财富管理等多元金融服务，业务覆盖美国沿海核心都会区。
LAB vs RBB — 直观对比
营收规模更大
RBB
是对方的1.7倍
$19.6M
营收增速更快
RBB
高出24.0%
-11.5%
净利率更高
RBB
高出208.9%
-177.4%
自由现金流更多
RBB
多$65.7M
$-23.1M
两年增速更快
RBB
近两年复合增速
-12.2%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $19.6M | $32.3M |
| 净利润 | $-34.7M | $10.2M |
| 毛利率 | 48.5% | — |
| 营业利润率 | -168.5% | 39.5% |
| 净利率 | -177.4% | 31.5% |
| 营收同比 | -11.5% | 12.6% |
| 净利润同比 | -28.8% | 132.1% |
| 每股收益（稀释后） | $-0.09 | $0.59 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LABRBB
| Q4 25 | — | $32.3M | ||
| Q3 25 | $19.6M | $32.6M | ||
| Q2 25 | $21.8M | $35.8M | ||
| Q1 25 | $40.8M | $28.5M | ||
| Q4 24 | — | $28.7M | ||
| Q3 24 | $22.1M | $30.3M | ||
| Q2 24 | $22.5M | $27.5M | ||
| Q1 24 | $45.5M | $28.2M |
净利润LABRBB
| Q4 25 | — | $10.2M | ||
| Q3 25 | $-34.7M | $10.1M | ||
| Q2 25 | $-33.5M | $9.3M | ||
| Q1 25 | $-26.0M | $2.3M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | $-26.9M | $7.0M | ||
| Q2 24 | $-45.7M | $7.2M | ||
| Q1 24 | $-32.2M | $8.0M |
毛利率LABRBB
| Q4 25 | — | — | ||
| Q3 25 | 48.5% | — | ||
| Q2 25 | 48.8% | — | ||
| Q1 25 | 48.4% | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 54.9% | — | ||
| Q2 24 | 46.1% | — | ||
| Q1 24 | 53.1% | — |
营业利润率LABRBB
| Q4 25 | — | 39.5% | ||
| Q3 25 | -168.5% | 40.7% | ||
| Q2 25 | -118.1% | 36.1% | ||
| Q1 25 | -80.8% | 11.2% | ||
| Q4 24 | — | 17.6% | ||
| Q3 24 | -120.9% | 31.6% | ||
| Q2 24 | -134.5% | 35.6% | ||
| Q1 24 | -132.2% | 39.9% |
净利率LABRBB
| Q4 25 | — | 31.5% | ||
| Q3 25 | -177.4% | 31.2% | ||
| Q2 25 | -153.7% | 26.1% | ||
| Q1 25 | -63.8% | 8.0% | ||
| Q4 24 | — | 15.3% | ||
| Q3 24 | -122.0% | 23.1% | ||
| Q2 24 | -203.3% | 26.4% | ||
| Q1 24 | -70.6% | 28.4% |
每股收益（稀释后）LABRBB
| Q4 25 | — | $0.59 | ||
| Q3 25 | $-0.09 | $0.59 | ||
| Q2 25 | $-0.09 | $0.52 | ||
| Q1 25 | $-0.07 | $0.13 | ||
| Q4 24 | — | $0.26 | ||
| Q3 24 | $-0.07 | $0.39 | ||
| Q2 24 | $-0.12 | $0.39 | ||
| Q1 24 | $-0.27 | $0.43 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $129.4M | $212.3M |
| 总债务越低越好 | — | $119.9M |
| 股东权益账面价值 | $399.7M | $523.4M |
| 总资产 | $539.6M | $4.2B |
| 负债/权益比越低杠杆越低 | — | 0.23× |
8季度趋势，按日历期对齐
现金及短期投资LABRBB
| Q4 25 | — | $212.3M | ||
| Q3 25 | $129.4M | $234.9M | ||
| Q2 25 | $158.6M | $191.9M | ||
| Q1 25 | $150.9M | $238.8M | ||
| Q4 24 | — | $257.7M | ||
| Q3 24 | $210.6M | $349.4M | ||
| Q2 24 | $269.8M | $252.8M | ||
| Q1 24 | $287.1M | — |
总债务LABRBB
| Q4 25 | — | $119.9M | ||
| Q3 25 | — | $119.8M | ||
| Q2 25 | — | $119.7M | ||
| Q1 25 | — | $119.6M | ||
| Q4 24 | — | $119.5M | ||
| Q3 24 | $55.2M | $119.4M | ||
| Q2 24 | $55.1M | $119.3M | ||
| Q1 24 | $55.0M | $119.2M |
股东权益LABRBB
| Q4 25 | — | $523.4M | ||
| Q3 25 | $399.7M | $514.3M | ||
| Q2 25 | $424.5M | $517.7M | ||
| Q1 25 | $454.6M | $510.3M | ||
| Q4 24 | — | $507.9M | ||
| Q3 24 | $489.3M | $509.7M | ||
| Q2 24 | $510.3M | $511.3M | ||
| Q1 24 | $577.3M | $514.0M |
总资产LABRBB
| Q4 25 | — | $4.2B | ||
| Q3 25 | $539.6M | $4.2B | ||
| Q2 25 | $557.0M | $4.1B | ||
| Q1 25 | $579.6M | $4.0B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | $681.5M | $4.0B | ||
| Q2 24 | $708.7M | $3.9B | ||
| Q1 24 | $777.7M | $3.9B |
负债/权益比LABRBB
| Q4 25 | — | 0.23× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.23× | ||
| Q4 24 | — | 0.24× | ||
| Q3 24 | 0.11× | 0.23× | ||
| Q2 24 | 0.11× | 0.23× | ||
| Q1 24 | 0.10× | 0.23× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-22.2M | $43.4M |
| 自由现金流经营现金流 - 资本支出 | $-23.1M | $42.6M |
| 自由现金流率自由现金流/营收 | -118.1% | 131.8% |
| 资本支出强度资本支出/营收 | 4.5% | 2.5% |
| 现金转化率经营现金流/净利润 | — | 4.26× |
| 过去12个月自由现金流最近4个季度 | $-111.1M | $73.5M |
8季度趋势，按日历期对齐
经营现金流LABRBB
| Q4 25 | — | $43.4M | ||
| Q3 25 | $-22.2M | $2.1M | ||
| Q2 25 | $-20.7M | $21.7M | ||
| Q1 25 | $-30.3M | $7.8M | ||
| Q4 24 | — | $58.5M | ||
| Q3 24 | $-27.9M | $24.5M | ||
| Q2 24 | $-39.0M | $11.7M | ||
| Q1 24 | $-62.5M | $4.8M |
自由现金流LABRBB
| Q4 25 | — | $42.6M | ||
| Q3 25 | $-23.1M | $1.8M | ||
| Q2 25 | $-22.6M | $21.6M | ||
| Q1 25 | $-35.3M | $7.6M | ||
| Q4 24 | — | $57.7M | ||
| Q3 24 | $-30.1M | $24.2M | ||
| Q2 24 | $-41.0M | $11.5M | ||
| Q1 24 | $-63.3M | $4.7M |
自由现金流率LABRBB
| Q4 25 | — | 131.8% | ||
| Q3 25 | -118.1% | 5.4% | ||
| Q2 25 | -103.6% | 60.2% | ||
| Q1 25 | -86.6% | 26.7% | ||
| Q4 24 | — | 201.0% | ||
| Q3 24 | -136.4% | 80.0% | ||
| Q2 24 | -182.2% | 42.0% | ||
| Q1 24 | -138.9% | 16.6% |
资本支出强度LABRBB
| Q4 25 | — | 2.5% | ||
| Q3 25 | 4.5% | 1.1% | ||
| Q2 25 | 8.7% | 0.3% | ||
| Q1 25 | 12.4% | 0.6% | ||
| Q4 24 | — | 2.7% | ||
| Q3 24 | 10.2% | 0.8% | ||
| Q2 24 | 8.6% | 0.5% | ||
| Q1 24 | 1.7% | 0.5% |
现金转化率LABRBB
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 2.32× | ||
| Q1 25 | — | 3.39× | ||
| Q4 24 | — | 13.34× | ||
| Q3 24 | — | 3.50× | ||
| Q2 24 | — | 1.61× | ||
| Q1 24 | — | 0.60× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |
RBB
暂无分部数据
